Trademarkia Logo

Canada

C$
TREELINE BIOSCIENCES
SEARCHED

on 14 Jan 2025

Last Applicant/ Owned by

Treeline Biosciences, Inc.

677 Washington BoulevardSuite 525Stamford, CT 06901

US

Serial Number

2142076 filed on 21st Oct 2021

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

TREELINE BIOSCIENCES

Trademark usage description

pharmaceutical products; biological preparations; pharmaceutical preparations for the prevention and treatment of cancer, autoimmune immunologic-based Read More

Classification Information


Class [005]
Pharmaceutical products; biological preparations; pharmaceutical preparations for the prevention and treatment of cancer, autoimmune immunologic-based diseases and other human diseases; biological preparations for the prevention and treatment of cancer, autoimmune diseases immunologic-based diseases and other human diseases; pharmaceutical, biological, and medicinal preparations for use in combination with other therapies for the treatment and prevention of cancer, autoimmune diseases, immunologic-based diseases and other human diseases; diagnostic biomarker reagents for medical purposes; diagnostic agents, preparations, and substances for medical purposes


Classification kind code

11

Class [042]
Pharmaceutical research and development; medical, pharmaceutical, and scientific research in the field of cancer, autoimmune diseases, immunologic-based diseases and other human diseases; medical, pharmaceutical, and scientific research in the field of biomarkers; clinical research and testing services; conducting clinical trials; providing medical and scientific research information in the field of pharmaceuticals and clinical trials


Classification kind code

11

Mark Details


Serial Number

2142076

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 22
on 14th Jan 2025
Search Recorded
Submitted for opposition 20
on 14th Jan 2025
Examiner's First Report
Submitted for opposition 48
on 2th Jul 2024
Agent Changed
Submitted for opposition 287
on 16th May 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 21st Oct 2021
Filed
Submitted for opposition 1
on 21st Oct 2021
Created
Submitted for opposition 31
on 21st Oct 2021
Formalized